Dudediligence.

4D Molecular Therapeutics, Inc

FDMTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

55.2M

on 2026-06-30, from 51.2M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

20M40M60MMar2024JunSepDecMar2025JunSepDec$10.51Mar2026Jun

Newest

$400.0M

S-3 of 2026-05-07. None sold under it to 2026-10-05. S-3 ↗

3 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-13 is not read yet.

Cash

9.3 quarters

$361.3M on 2026-06-30 ÷ $39.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-11-06Public offering incl. 1.13M pre-funded9,514,758$10.51$100.0M424B5 ↗

Also on file: up to $200.0M term loans agreed 2026-06-24 8-K ↗